CVAT — Cavitation Technologies Income Statement
0.000.00%
- $7.69m
- $7.15m
- $1.36m
- 57
- 30
- 69
- 51
Annual income statement for Cavitation Technologies, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.66 | 0.558 | 1.67 | 0.433 | 1.36 |
Cost of Revenue | |||||
Gross Profit | 1.62 | 0.538 | 1.62 | 0.312 | 1.21 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1.53 | 1.2 | 1.86 | 1.32 | 0.925 |
Operating Profit | 0.136 | -0.643 | -0.195 | -0.886 | 0.438 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.128 | -0.649 | -0.619 | -2.04 | 0.439 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.128 | -0.649 | -0.619 | -2.04 | 0.439 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.128 | -0.649 | -0.619 | -2.04 | 0.439 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.128 | -0.649 | -0.619 | -2.04 | 0.439 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.001 | -0.004 | -0.002 | -0.007 | 0.002 |